Trial Profile
Efficacy and Safety of Radiotherapy Concurrently Combined With Cisplatin and Nimotuzumab for Patients With Locally Advanced Cervical Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Nimotuzumab (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 14 Mar 2016 New trial record